# US 2025/0375463 A1 · Nutraceutical composition for combating aging in human and non-human animals and beverages and/or food products and/or food supplements containing the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0375463 A1
- Document ID: US20250375463A1
- Status: Published application
- Kind: A1
- Application number: 19/228,557
- Filed: 2025-06-04
- Published: 2025-12-11
- Earliest claimed: 2024-06-11
- Inventors: DOUGLAS JAY SPIEL; RAYMOND ANTHONY JOAO
- Web page: https://patentgrep.com/patent/US20250375463A1

## CPC

- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 31/706: containing six-membered rings with nitrogen as a ring hetero atom
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/09: having two or more such linkages
- A61K 31/132: having two or more amino groups, e.g. spermidine, putrescine
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/205: Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A61K 31/26: Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
- A61K 31/275: Nitriles; Isonitriles
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 31/37: Coumarins, e.g. psoralen
- A61K 31/4375: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A61K 31/4525: containing a five-membered ring with oxygen as a ring hetero atom
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 31/7008: Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
- A61K 31/728: Hyaluronic acid
- A61K 31/737: Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K31/727 takes precedence)
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 36/41: Crassulaceae (Stonecrop family)
- A61K 36/54: Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A61K 36/5777: {Theobroma, e.g. cocao or cocoa}
- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61K 36/9068: Zingiber, e.g. garden ginger
- A61K 38/063: {Glutathione}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A nutraceutical composition, consisting of Nicotinamide Riboside in a range of 100-2000 mg or Nicotinamide Mononucleotide in a range 250-1000 mg, Spermidine in a range 0.5-10 mg, Rhodiola Rosea in a range 200-600 mg, Cacao in a range 1000-10,000 mg, L-Theanine in a range 50-200 mg, Glucosamine in a range 500-3000 mg, and Hyaluronic acid in a range 50-240 mg, or consisting of Epigallocatechin-3-gallate in a range 100-500 mg, Quercetin in a range 250-1000 mg, Resveratrol in a range 150-1000 mg, Sulforaphane in a range 1-50 mg, and Calcium Alphaketoglutarate in a range 300-2000 mg, or consisting of Microdose Lithium in a range 1-5 mg, Trimethylglycine in a range 500-2000 mg, Glutathione in a range 250-1000 mg, Fisetin in a range 100-1000 mg, Urolithin A in a range 250-2000 mg, Sodium Butyrate in a range 100-3000 mg, Berberine in a range 500-1500 mg, Apigenin in a range 50-500 mg, Cinnamon in a range 1000-6000 mg, and Malate in a range 1000-6000 mg.

## Claims

### Claim 1

A nutraceutical composition, wherein a serving of the nutraceutical composition consists at least of Nicotinamide Riboside (NR) in an amount of 100 to 2000 mg, or Nicotinamide Mononucleotide (NMN) in an amount of about a range of 250 to 1000 mg, Spermidine in an amount of about a range of 0.5 to 10 mg, Rhodiola Rosea in an amount of about a range of 200 to 600 mg, Cacao in an amount of about a range of 1000 to 10,000 mg, L-Theanine in an amount of about a range of 50 to 200 mg, Glucosamine in an amount of about a range of 500 to 3000 mg, and Hyaluronic acid in an amount of about a range of 50 to 240 mg.

### Claim 2 (depends on 1)

The nutraceutical composition of claim 1, wherein the nutraceutical composition further consists of Ginger in an amount of about a range of 500 to 3000 mg.

### Claim 3 (depends on 1)

The nutraceutical composition of claim 1, wherein the nutraceutical composition further consists of Turmeric in an amount of about a range of 500 to 2000 mg.

### Claim 4 (depends on 1)

The nutraceutical composition of claim 1, wherein the nutraceutical composition further consists of Caffeine in an amount of about a range of 50 to 200 mg.

### Claim 5

A nutraceutical composition, wherein a serving of the nutraceutical composition consists at least of Epigallocatechin-3-gallate (EGCG) in an amount of about a range of 100 to 500 mg, Quercetin in an amount of about a range of 250 to 1000 mg, Resveratrol in an amount of about a range of 150 to 1000 mg, Sulforaphane in an amount of about a range of 1 to 50 mg, and Calcium Alphaketoglutarate (CaAKG) in an amount of about a range of 300 to 2000 mg.

### Claim 6 (depends on 5)

The nutraceutical composition of claim 5, wherein the nutraceutical composition further consists of Fucoidan in an amount of about a range of 100-4000 mg

### Claim 7 (depends on 5)

The nutraceutical composition of claim 5, wherein the nutraceutical composition further consists of Pterostilbene in an amount of about a range of 50-250 mg.

### Claim 8 (depends on 5)

The nutraceutical composition of claim 5, wherein the nutraceutical composition further consists of Turmeric in an amount of about a range of 500 to 2000 mg.

### Claim 9 (depends on 5)

The nutraceutical composition of claim 5, wherein the nutraceutical composition further consists of Piperine in an amount of about a range of 1 to 30 mg.

### Claim 10 (depends on 5)

The nutraceutical composition of claim 5, wherein the nutraceutical composition further consists of Ginger in an amount of about a range of 500 to 3000 mg.

### Claim 11

A nutraceutical composition, wherein a serving of the nutraceutical composition consists at least of Microdose Lithium in an amount of about a range of 1 to 5 mg, Trimethylglycine (TMG) in an amount of about a range of 500 to 2000 mg, Glutathione in an amount of about a range of 250 to 1000 mg, Fisetin in an amount of about a range of 100 to 1000 mg, Urolithin A in an amount of about a range of 250 to 2000 mg, Sodium Butyrate in an amount of about a range of 100-3000 mg, Berberine in an amount of about a range of 500 1500 mg, Apigenin in an amount of about a range of 50 to 500 mg, Cinnamon in an amount of about a range of 1000 to 6000 mg, and Malate in an amount of about a range of 1000 to 6000 mg.

### Claim 12 (depends on 11)

The nutraceutical composition of claim 11, wherein the nutraceutical composition further consists of Turmeric in an amount of about a range of 500 to 2000 mg.

### Claim 13 (depends on 11)

The nutraceutical composition of claim 11, wherein the nutraceutical composition further consists of Epigallocatechin-3-gallate (EGCG) in an amount of about a range of 100 to 500 mg.

### Claim 14 (depends on 11)

The nutraceutical composition of claim 11, wherein the nutraceutical composition further consists of Cacao in an amount of about a range of 1000 to 10,000 mg.

### Claim 15 (depends on 1)

The nutraceutical composition of claim 1, wherein the nutraceutical composition is produced in a powder form.

### Claim 16 (depends on 5)

The nutraceutical composition of claim 5, wherein the nutraceutical composition is produced in a powder form.

### Claim 17 (depends on 11)

The nutraceutical composition of claim 11, wherein the nutraceutical composition is produced in a powder form.

### Claim 18 (depends on 1)

The nutraceutical composition of claim 1, wherein the nutraceutical composition is an ingredient of an energy drink, a protein drink, or a vitamin drink.

### Claim 19 (depends on 5)

The nutraceutical composition of claim 5, wherein the nutraceutical composition is an ingredient of an energy drink, a protein drink, or a vitamin drink.

### Claim 20 (depends on 11)

The nutraceutical composition of claim 11, wherein the nutraceutical composition is an ingredient of an energy drink, a protein drink, or a vitamin drink, or wherein the nutraceutical composition contains Nicotinamide Riboside (NR) in an amount of 100 to 2000 mg.
